SCHEMBL14660736

SCHEMBL14660736

CC(O)C(Cl)NC(c1ccccc1)c1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.42
ADRA2C P18825 2/20 0.42
CYP3A4 P08684 2/20 0.42
ALOX15 P16050 2/20 0.42
CHRM2 P08172 1/20 0.42
ADRA1A P35348 1/20 0.42
RGS12 O14924 1/20 0.42
GLA P06280 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C9 P11712 1/20 0.42
PKM P14618 1/20 0.42
ALOX12 P18054 1/20 0.42
NFKB1 P19838 1/20 0.42
HTR2A P28223 1/20 0.42
CYP2C19 P33261 1/20 0.42
THPO P40225 1/20 0.42
GNAI1 P63096 1/20 0.42
HSD17B10 Q99714 1/20 0.42
KMT2A Q03164 4/20 0.41
MEN1 O00255 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7991731 0.79 ADRA2C (0.48) TSHRADRA2CCYP3A4ALOX15CHRM2
SCHEMBL9843925 0.73 MTOR (0.48) TSHRADRA2CCYP3A4ALOX15CHRM2
SCHEMBL3281034 0.72 MTOR (0.57) TSHRCYP3A4ALOX15CYP2D6HTR2A
SCHEMBL4778223 0.72 LMNA (0.48) TSHRADRA2CCYP3A4ALOX15CHRM2
SCHEMBL21836227 0.72 SIGMAR1 (0.55) TSHRCYP3A4ALOX15CHRM2ADRA1A
SCHEMBL21836226 0.72 SIGMAR1 (0.55) TSHRCYP3A4ALOX15CHRM2ADRA1A
SCHEMBL1696698 0.71 TDP1 (0.54) TSHRADRA2CCYP3A4ALOX15CHRM2
SCHEMBL11100775 0.70 MTOR (0.44) TSHRADRA2CCYP3A4ALOX15CHRM2
SCHEMBL28984180 0.70 LMNA (0.46) TSHRADRA2CCYP3A4ALOX15KDM4E
SCHEMBL8766752 0.69 LMNA (0.49) TSHRCYP2D6HSD17B10KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2736895-A1 2 - (2, 4, 5 - SUBSTITUTED -ANILINO) PYRIMIDINE DERIVATIVES AS EGFR MODULATORS USEFUL FOR TREATING CANCER Astrazeneca AB (SE) 2014-06-04 EP disclosed
WO-2013014448-A1 2 - (2, 4, 5 - SUBSTITUTED -ANILINO) PYRIMIDINE DERIVATIVES AS EGFR MODULATORS USEFUL FOR TREATING CANCER ASTRAZENECA AB (SE) 2013-01-31 WO disclosed